Description: MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.
Home Page: www.mmpharm.co.kr
7, Gangnam-daero
Seoul,
06258
South Korea
Phone:
82 2 6711 2000
Officers
| Name | Title |
|---|---|
| Mr. Kyu-Huok Lee | Chairperson, Chief Exec. Officer and Pres |
| Mr. Ki-Beom Kim | Managing Director |
| Yong-Kyeong Seong | Managing Director and Devel. Support Director |
| Mr. Choon-Sik Park | Managing Director |
| Mr. Chul-Han Bae | Sr. Managing Director |
| Pil-Yeong So | Sr. Managing Director |
| Hong-Nyeon Kim | Managing Director |
| Min-Ho Ki | Managing Director |
| Yeong-Mi Lee | Managing Director |
| Tae-Seob Hwang | Managing Director and Chief of Central Research Center |
Exchange: KO
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2575 |
| Price-to-Sales TTM: | 0.7024 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |